Key points are not available for this paper at this time.
Summary Oral administration of tranexamic acid, in a dosage of 3 g daily from the first day of menstruation onwards, significantly decreases menstrual haemoglobin loss in women with so-called essential menorrhagia. The frequency of side-effects reported did not differ between “active” and “placebo” periods.
Vermylen et al. (1968) studied this question.